drugset / Trial / NCT03081897
Regional Anaesthesia and Substance P in Head and Neck Cancer
RandomizedParallel-groupOpen-labelSupportive care
Summary
In the clinical trial the investigators will observe the impact of regional anesthesia in addition to a general anesthesia on the expression of substance P in patients with unilateral Head or Neck cancer undergoing unilateral Neck Dissection. The investigators will perform an unilateral regional cervical plexus block on the tumor side. The tissue of the tumor side will be analysed by immunohistology, measuring the expression of the Substance P.
Timeline
- Start
- 2016-07
- Primary completion
- 2023-07-01
- Completion
- 2023-07-01
Outcome
Outcome not reported
Stopped: “for organizational reasons”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropivacaine | Other / unclassified | 0.75 % | Other |
| Background | Propofol | Small molecule | 2 mg/kg | — |
| Background | Remifentanil | Small molecule | 0.1 ug/kg | — |
| Background | Remifentanil | Small molecule | 0.4 ug/kg | — |